Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.
作者： Tomonori Nakamura , Tomoko Terajima , Taeko Ogata , Koichi Ueno , Naotake Hashimoto
DOI: 10.1248/BPB.29.1167
关键词: Nicotinamide 、 Endocrinology 、 Internal medicine 、 Hyperlipidemia 、 Insulin 、 Glucose tolerance test 、 Insulin resistance 、 Type 2 diabetes 、 Diabetes mellitus 、 Medicine 、 Streptozotocin
摘要: … mouse model is useful for searching drugs that are beneficial to treatment of the non-obese type 2 diabetes. … if the optimal protocol procedures induce pathophysiological features of a …
elsevier.com
sci-hub.se 参考文章(25)
K. U. Lee, C. S. Koh, H. K. Min, H. K. Lee, Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man Diabetologia. ,vol. 31, pp. 285- 290 ,(1988) , 10.1007/BF00277409
H Schmid-Antomarchi, J De Weille, M Fosset, M Lazdunski, The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. Journal of Biological Chemistry. ,vol. 262, pp. 15840- 15844 ,(1987) , 10.1016/S0021-9258(18)47664-8
D A Cooney, P S Schein, M L Vernon, The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity. Cancer Research. ,vol. 27, pp. 2324- 2332 ,(1967)
Mikio Ito, Yoichi Kondo, Akiko Nakatani, Koji Hayashi, Atsuhiko Naruse, Characterization of low dose streptozotocin-induced progressive diabetes in mice Environmental Toxicology and Pharmacology. ,vol. 9, pp. 71- 78 ,(2001) , 10.1016/S1382-6689(00)00064-8
M.-H. Giroix, A. Nadi, A. Sener, B. Portha, W. Malaisse, Metabolism of D-[3-3H]glucose, D-[5-3H]glucose, D-[U-14c]glucose, D-[1-14C]glucose and D-[6-14C]glucose in pancreatic islets in an animal model of type-2 diabetes International Journal of Molecular Medicine. ,vol. 9, pp. 381- 384 ,(2002) , 10.3892/IJMM.9.4.381
Loren G. Lipson, Diabetes in the elderly: Diagnosis, pathogenesis, and therapy The American Journal of Medicine. ,vol. 80, pp. 10- 21 ,(1986) , 10.1016/0002-9343(86)90533-4
S. G. Paik, N. Fleischer, S. I. Shin, Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes Proceedings of the National Academy of Sciences of the United States of America. ,vol. 77, pp. 6129- 6133 ,(1980) , 10.1073/PNAS.77.10.6129
Hiroshi Yamamoto, Yasuko Uchigata, Hiroshi Okamoto, Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature. ,vol. 294, pp. 284- 286 ,(1981) , 10.1038/294284A0
S. Nagasaka, Y. Aiso, K. Yoshizawa, S. Ishibashi, Comparison of pioglitazone and metformin efficacy using homeostasis model assessment Diabetic Medicine. ,vol. 21, pp. 136- 141 ,(2004) , 10.1111/J.1464-5491.2004.01083.X
Tom Anderson, Philip S. Schein, Mary G. McMenamin, David A. Cooney, Streptozotocin Diabetes CORRELATION WITH EXTENT OF DEPRESSION OF PANCREATIC ISLET NICOTINAMIDE ADENINE DINUCLEOTIDE Journal of Clinical Investigation. ,vol. 54, pp. 672- 677 ,(1974) , 10.1172/JCI107805